X-49030444-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_006521.6(TFE3):c.1442G>T(p.Gly481Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,209,474 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 2 hem., cov: 22)
Exomes 𝑓: 0.000023 ( 0 hom. 6 hem. )
Consequence
TFE3
NM_006521.6 missense
NM_006521.6 missense
Scores
4
13
Clinical Significance
Conservation
PhyloP100: 1.38
Genes affected
TFE3 (HGNC:11752): (transcription factor binding to IGHM enhancer 3) This gene encodes a basic helix-loop-helix domain-containing transcription factor that binds MUE3-type E-box sequences in the promoter of genes. The encoded protein promotes the expression of genes downstream of transforming growth factor beta (TGF-beta) signaling. This gene may be involved in chromosomal translocations in renal cell carcinomas and other cancers, resulting in the production of fusion proteins. Translocation partners include PRCC (papillary renal cell carcinoma), NONO (non-POU domain containing, octamer-binding), and ASPSCR1 (alveolar soft part sarcoma chromosome region, candidate 1), among other genes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant X-49030444-C-A is Benign according to our data. Variant chrX-49030444-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 2528748.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFE3 | NM_006521.6 | c.1442G>T | p.Gly481Val | missense_variant | 10/10 | ENST00000315869.8 | NP_006512.2 | |
TFE3 | NM_001282142.2 | c.1127G>T | p.Gly376Val | missense_variant | 10/10 | NP_001269071.1 | ||
TFE3 | XM_024452432.2 | c.*72G>T | 3_prime_UTR_variant | 11/11 | XP_024308200.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFE3 | ENST00000315869.8 | c.1442G>T | p.Gly481Val | missense_variant | 10/10 | 1 | NM_006521.6 | ENSP00000314129 | P1 | |
TFE3 | ENST00000493583.5 | c.*1047G>T | 3_prime_UTR_variant, NMD_transcript_variant | 10/10 | 2 | ENSP00000476976 |
Frequencies
GnomAD3 genomes AF: 0.0000180 AC: 2AN: 111242Hom.: 0 Cov.: 22 AF XY: 0.0000598 AC XY: 2AN XY: 33420
GnomAD3 genomes
AF:
AC:
2
AN:
111242
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33420
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 182148Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67310
GnomAD3 exomes
AF:
AC:
5
AN:
182148
Hom.:
AF XY:
AC XY:
1
AN XY:
67310
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000228 AC: 25AN: 1098232Hom.: 0 Cov.: 37 AF XY: 0.0000165 AC XY: 6AN XY: 363600
GnomAD4 exome
AF:
AC:
25
AN:
1098232
Hom.:
Cov.:
37
AF XY:
AC XY:
6
AN XY:
363600
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000180 AC: 2AN: 111242Hom.: 0 Cov.: 22 AF XY: 0.0000598 AC XY: 2AN XY: 33420
GnomAD4 genome
AF:
AC:
2
AN:
111242
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MutPred
Loss of relative solvent accessibility (P = 0.0071);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at